C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
530/5.06, 260/31
C07K 5/06 (2006.01) C07D 209/20 (2006.01) C07K 5/078 (2006.01)
Patent
CA 1294737
Abstract of the Invention In general, the invention features compounds having the formula: Image or a pharmaceutically acceptable salt thereof, wherein each R1 is, independently, an alkyl group having 1 to 5, inclusive, carbon atoms, an alkoxy group having 1 to 5, inclusive, carbon atoms, a halogen, amino, hydroxy, nitro, cyano, carboxyl, trifluoreomethyl, ethyl carboxylate, or a hydrogen; m is an integer between 0 and 2, inclusive,; and A is either -(CH2)n-?-R2, where n is an integer between 1 and 5, inclusive, and R is hydroxy, an alkoxy group having 1 to 5, inclusive, carbon atoms, aralkoxy (e.g., benzyloxy), aralkyl (e.g., benzyl), amino, an alkyl group having 1 to 5, inclusive, carbon atoms, an alkylamino group having 1 to 5, inclusive, carbon atoms, a dialkylamino group with each alkyl group, independently having 1 to 5, inclusive, carbon atoms, a cycloalkylamino group wherein the ring has 4 to 6, inclusive, carbon atoms (e.g., pyrrolidino, piperidino, N-methylpiperazino), or morpholino; or A is an alkyl group having 1 to 5, inclusive, carbon atoms, a hydroxyalkyl group having 1 to 5, inclusive, carbon atoms, an alkoxyalkyl group having 2 to 8, inclusive, carbon atoms, an aralkoxyalkyl having 8 to 14, inclusive, carbon atoms, an aryl group (e.g., phenyl, toluyl) having 6 to 14, inclusive, carbon atoms, an aralkyl group (e.g., benzyl, phenylethyl) having 6 to 14, inclusive, carbon atoms, and a cycloalkyl group having 3 to 12, inclusive, carbon atoms. These com- pounds find use as cholestokinin (or CCK) antagonists.
526443
Biomeasure Inc.
Smart & Biggar
LandOfFree
Cck antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cck antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cck antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1262399